# Plasma Derived from Therapeutic Plasma Exchange - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/memorandum/plasma-derived-from-therapeutic-plasma-exchange/83d64ec6-ba80-482f-a450-aac3b802f645

> FDA guidance document: Plasma Derived from Therapeutic Plasma Exchange. Issue date: December 14, 1984. Get complete insights and analysis.

---

## Details

- Title: Plasma Derived from Therapeutic Plasma Exchange
- Communication Type: Memorandum
- Product Type: biologics
- Office Name: Center for Biologics Evaluation and Research
- Office URL: /offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
- Issue Date: 1984-12-14
- Last Changed: 2020-07-16
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2013-S-0613">FDA-2013-S-0613</a>

## Related Documents

- [Volume Limits for Automated Collection of Source Plasma](https://www.globalkeysolutions.net/guidances/memorandum/volume-limits-for-automated-collection-of-source-plasma/c00375ca-2408-4bc5-9774-51befd13a7d0)
- [Revised Recommendations for Testing Whole Blood, Blood Components, Source Plasma and Source Leukocytes for Antibody to Hepatitis C Virus Encoded Antigen (Anti-HCV)](https://www.globalkeysolutions.net/guidances/memorandum/revised-recommendations-for-testing-whole-blood-blood-components-source-plasma-and-source-leukocytes-for-antibody-to-hepatitis-c-virus-encoded-antigen-anti-hcv/fec579ab-4311-4caf-a1d4-a68957466e0e)
- [Donor Deferral Due to Red Blood Cell Loss During Collection of Source Plasma by Automated Plasmapheresis](https://www.globalkeysolutions.net/guidances/memorandum/donor-deferral-due-to-red-blood-cell-loss-during-collection-of-source-plasma-by-automated-plasmapheresis/5e298c66-6f31-48eb-ac26-66adf2b26fe6)